Sclerotherapy with or without octreotide for acute variceal bleeding

New England Journal of Medicine

Volumn 333, Issue 9, 1995, Pages 555-560

  Besson, Isabelle ^a   Ingrand, Pierre ^a   Person, Bruno ^a   Boutroux, Dominique ^a   Heresbach, Denis ^a   Bernard, Pierre ^a   Hochain, Patrick ^a   Larricq, Jacques ^a   Gourlaouen, Alain ^a   Ribard, Didier ^a   Kara, Nassim Mostefa ^a   Legoux, Jean Louis ^a   Pillegand, Bernard ^a   Becker, Marie Claude ^a   di Costanzo, Jacques ^a   Metreau, Jean Michel ^a   Silvain, Christine ^a   Beauchant, Michel ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INFUSION FLUID; LACTULOSE; OCTREOTIDE; POLIDOCANOL; SCLEROSING AGENT; VITAMIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; FEMALE; HEADACHE; HEPATIC ENCEPHALOPATHY; HEPATORENAL SYNDROME; HUMAN; HYPERGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ACUTE DISEASE; ADULT; AGED; BLOOD TRANSFUSION; DOUBLE-BLIND METHOD; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; OCTREOTIDE; PROSPECTIVE STUDIES; RECURRENCE; REGRESSION ANALYSIS; SCLEROTHERAPY; SURVIVAL RATE; TREATMENT FAILURE;

EID: 0029154559     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199508313330904     Document Type: Article

References (23)

1. Graham DY, Smith JL The course of patients after variceal hemorrhage. Gastroenterology 1981; 80: 800-809
2. Thomsen BL, Moller S, Sorensen TIA, Copenhagen Esophageal Varices Sclerotherapy Project. Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. J Hepatol 1994; 21: 367-375
3. Moller S, Sorensen TIA, Tygstrup N, Copenhagen Esophageal Varices Sclerotherapy Project. Who benefits from endoscopic sclerotherapy of bleeding oesophageal varices? Proposal for different indications. J Hepatol 1992; 15: 184-191
4. Terblanche J, Burroughs AK, Hobbs KEF Controversies in the management of bleeding esophageal varices. N Engl J Med 1989; 320: 1393-1398
5. Burroughs AK, Hamilton G, Phillips A, Mezzanotte G, McIntyre N, Hobbs KEF A comparison of sclerotherapy with staple transection of the esophagus for the emergency control of bleeding from esophageal varices. N Engl J Med 1989; 321: 857-862
6. McCormick PA, Dick R, Siringo S, Octreotide reduces azygos blood flow in cirrhotic patients with portal hypertension. Eur J Gastroenterol Hepatol 1990; 2: 489-492
7. McKee R A study of octreotide in oesophageal varices. Digestion 1990; 45: Suppl 1: 60-64
8. Huang CC, Sheen IS, Chu CM, A prospective randomized controlled trial of sandostatin and vasopressin in the management of acute bleeding esophageal varices. Chang Keng I Hsueh 1992; 15: 78-83
9. Hwang SJ, Lin HC, Chang CF, A randomized controlled trial comparing octreotide and vasopressin in the control of acute esophageal variceal bleeding. J Hepatol 1992; 16: 320-325
10. Silvain C, Carpentier S, Sautereau D, Terlipressin plus transdermal nitroglycerin vs. octreotide in the control of acute bleeding from esophageal varices: a multicenter randomized trial. Hepatology 1993; 18: 61-65
11. Planas R, Quer JC, Boix J, A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding. Hepatology 1994; 20: 370-375
12. Sung JJY, chung SC, Lai CW, Octreotide infusion or emergency sclerotherapy for variceal haemorrhage. Lancet 1993; 342: 637-641
13. Avgerinos A, Klonis C, Rekoumis G, Gouma P, Papadimitriou N, Raptis S A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhage. J Hepatol 1991; 13: 78-83
14. Fiaccadori F, Pedretti G, Biraghi M, Arcidiacono R Terlypressin and endoscopic sclerotherapy control variceal bleeding and prevent early rebleeding in cirrhotic patients. Curr Ther Res 1993; 54: 519-528
15. de Franchis R, Pascal JP, Ancona E, Definitions, methodology and therapeutic strategies in portal hypertension: a Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992; 15: 256-261
16. Burroughs AK, McCormick PA, Hughes MD, Sprengers D, D'Heygere F, McIntyre N Randomized, double-blind, placebo-controlled trial of somatostatin for variceal bleeding: emergency control and prevention of early variceal rebleeding. Gastroenterology 1990; 99: 1388-1395
17. Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60: 646-649
18. Armitage P, Berry G. Statistical methods in medical research. 2nd ed. Oxford, England: Blackwell, 1987.
19. SAS/STAT guide for personal computers, version 6 ed. Cary, n.C.: SAS Institute, 1987.
20. Shields R, Jenkins SA, Baxter JN, A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices. J Hepatol 1992; 16: 128-137
21. Barsoum MS, Bolous FI, El-Rooby AA, Rizk-Allah MA, Ibrahim AS Tamponade and injection sclerotherapy in the management of bleeding oesophageal varices. Br J Surg 1982; 69: 76-78
22. Albillos A, Colombato LA, Lee FY, Groszmann RJ Octreotide ameliorates vasodilatation and Na+ retention in portal hypertensive rats. Gastroenterology 1993; 104: 575-579
23. Dudley FJ somatostatin and portal hypertensive bleeding: a safe therapeutic alternative? Gastroenterology 1992; 103: 1973-1977